Editorial The role of T-cell derived cytokines in allergic diseases

References to Primary Literature

• MOSMMANN TR, COFFMAN RI: ml and Th2 cells: differ-ent patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. (1989) 7:145–173.
   PubMedGoogle Scholar
• ROMAGNANI S: Lymphokine production by human T-eens in disease states. Annu. Rev. Immunol (1994) 12:227–257.
   PubMed Web of Science ®Google Scholar
• ROMAGNANI S: Biology of human Thl and Th2 cells. J.Clin. Immunol. (1995) 15:121–126.
   PubMed Web of Science ®Google Scholar
• WIERENGA EA, SNOEK M, DE GROOT C, CHRETIEN I, BOS JD, JANSEN HM, KAPSENBERG ML: Evidence for compart-mentalisation of functional subsets of CD4+ T lympho-cytes Inatopic patknts. J. Immunol. (1990) 144:4651–4656.
   PubMed Web of Science ®Google Scholar
• PARRONCHI P, MACCHIA D, PICCINNI M-P, BISWAS P, SIMONELLI C, MAGGI E, RICCI M, ANSARI AA, ROMAGNANI S: Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sct. USA (1991) 88:4538–4542,
   PubMed Web of Science ®Google Scholar
• MAGGI E, BISWAS P, DEL PRETE GF, PARRONCHI P, MACCHIA D, SIMONELLI C, EMMI L, DE CARLI M, TIRI A, RICCI M, ROMAGNANI S: Accumulation of Th2-11ke helper T-cells in the conjuctiva of patients with vernal conjunctivitis. J. Immunol. (1991) 146:1169–1174,
   PubMed Web of Science ®Google Scholar
• VAN DER HEIJDEN FL, WIERENGA EA, BOS JD, KAPSEN-BERG ML: High frequency of 11-4-producing CD4+ aller-gen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Derrnatol. (1991) 97:389–394.
   PubMedGoogle Scholar
• HAMID Q, AZZAWI M, YING S, MOQBEL R, WARDLAW AJ, CORRIGAN CJ, BRADLEY B, DURHAM SR, COLLINS JV, JEFFREY PK, QUINT DJ, KAY AB: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. (1991) 87:1541–1546.
   PubMed Web of Science ®Google Scholar
• ROBINSON DS, HAMID Q, YING S, TSICOPOULOS A, BARKANS J, BENTLEY AM, CORRIGAN CJ, DURHAM SR, KAY AB: Predominant Th2-like bronchoalveolar T-lym-phocyte population in atopic asthma. New Engl. J. Med. (1992) 326:295–304.
   Web of Science ®Google Scholar
• DEL PRETE GF, DE CARLI M, D'ELIOS MM, MAESTRELLI P, RICCI M, FABBRI L, ROMAGNANI S: Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. (1993) 23:1445–1449.
   PubMed Web of Science ®Google Scholar
• VARNEY VA, HAMID Q, GAGA M, YING S, JACOBSON M, FREW AJ, KAY AB, DURHAM SR: Influence of grass pollen immtmotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin. Invest. (1993) 92:644–651.
   PubMed Web of Science ®Google Scholar
• SECRIST H, CHELEN CJ, WEN Y, MARSHALL JD, UMETSU DT: Allergen immunotherapy decreases interleukin-4 production in C04+ T-cells from allergic individuals. J. Exp. Med. (1993) 178:2123–2130.
   PubMed Web of Science ®Google Scholar
• JUTEL M, PICHLER WJ, SKRBIC D, URWYLER A, DAH1NDEN C, MULLER UR: Bee venom immunotherapy results in decrease of 11-4 and IL-5 and increase of IFN-y secretion In specific allergen-stimulated T-cell cultures. J. Immu-nol. (1995) 154:4187–4194.
   PubMed Web of Science ®Google Scholar
• DEL PRETE GF, DE CARLI M, ALMERIGOGNA F, DANIEL CK, D'ELIOS MM, ZANCUOGFII G, PIZZOLO G, ROMAG-NANI S: Preferential expression of CD30 by human CD4+ T-cells producing Th2-type cytokines. FASEB J. (1995) 9:81–86.
   PubMed Web of Science ®Google Scholar
• SWAIN SL: IL-4 dictates T-cell differentiation. Res. Immu-nol. (1993) 144:616–620.
   PubMedGoogle Scholar
• SEDER RA, PAPUL WE, DAVIS MM, FAZEKAS DE ST GROTH B: The presence of interleukin-4 during in vitro prim-ing determines the lymphocyte-producing potential of CD4+ T-cells from T-cell receptor transgenic mice. J. Exp. Med. (1992) 176:1091–1098.
   PubMed Web of Science ®Google Scholar
• MAGGI E, PARRONCHI P, MANETIT R, SIMONELLI C, PIC-CINNI M-P, SANTONI-RUGIU F, DE CARLI M, RICCI M, ROMAGNANI S: Reciprocal regulatory role of IFN-7 and 1I-4 on the in vitro development of human Thl and Th2 clones. J. Immunol. (1992) 148:2142–2147.
   PubMed Web of Science ®Google Scholar
• KOPF M, LE GROS G, BACHMANN M, LAMERS MC, BLUTH-MANN H, KOHLER G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (1993) 362:245–248.
   PubMed Web of Science ®Google Scholar
• BRADDING P, FEATHER IH, HOWARTH PH, MUELLER R, ROBERTS JA, BRITTEN K, BEWS JPA, HUNT TC, OKAYAMA Y, HEUSSER CH, BULLOCK GR, CHURCH MK, HOLGATE ST: Interleukin 4 is localised and released by human mast cells. J. Exp. Med. (1992) 176:1381–1386.
   PubMed Web of Science ®Google Scholar
• BRUNNER T, HEUSSER CH, DAHINDEN CA: Human pe-ripheral blood basophils primed by interleukin 3 (11-3) produce IL-4 in response to immunoglobulin E recep-tor stimulation. J. Exp. Med. (1993) 177:605–611.
   PubMed Web of Science ®Google Scholar
• MOQBEL R, YING S, BARKANS J, NEWMAN TM, ximmirr P, VAKELIN M, TABORDA-BARATA L, MENG Q, CORRIGAN CJ, DURHAM SR, KAY AB: Identification of mRNA for interleukin-4 in human eosinophlls with granule local-isation and release of the translated product. J. Immunol. (1995) 155: 1939–1947.
   Google Scholar
• YASHIMOTO T, PAUL WE: CD4+, NK1.1+ T-cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. E. Med. (1994) 179:1285–1295.
   Google Scholar
• PFEIFFER C, STEIN J, SOUTHWOOD S„ KETELAAR H, SETTE A, BOTTOMLY K: Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. (1995) 181:1569–1574
   PubMed Web of Science ®Google Scholar
• KALINSKI P, HILKENS CMU, WIERENGA EA, VAN DER POUW-KRAAN TCTM, VAN LIER RAW, BOS JD, KAPSEN-BERG ML, SNIJDEWINT FGM: Functional maturation of human naive T helper cells in the absence of accessory cells. Generation of IL-4-producing T helper cells does not require exogenous IL-4.J. Immunol. (1995) 154:3753–3760.
   Google Scholar
• DEMEURE CE, YANG LP, BYUN DG, ISHIHARA H, VEZZION, DELESPESSE G: Human naive CD4 T-cells produce interleukin-4 at priming and acquire a 'fh2 phenotype upon repetitive stimulations in neutral conditions. Eur. J. Irnmunol. (1996) 25:2722–2725.
   Google Scholar
• WERSHIL BK, THEODOS CM, GALLI SJ, TITUS RG: Mastcells augment lesion size and persistence during experi-mental Leisbmania major infection in the mouse. J. Immunol. (1994) 152:4563–4571.
   PubMedGoogle Scholar
• SCHMITZ J, THIEL A, KUHN R, RAJEWSKY K, MULLER M,ASSENMACHER M, RADBRUCH A: Induction of inter-leukin-4 (IL-4) expression in T helper (Th) cells is not dependent on II-4 from non-T-cells. J. Exp. Med. (1994) 179:1349–1353.
   PubMed Web of Science ®Google Scholar
• YASHIMOTO T, BENDELAC A, WATSON C, HU-LI J, PAUL WE: CD-1-specific, NK1.1+ T-cells play a key in vivo role in a Th2 response and in IgE production. Science (1995) in press.
   Google Scholar
• YASHIMOTO T, BENDELAC A, HU-LI J, PAUL WE: Defective IgE production by SJL mice is linked to the absence of a subset of T-cells that promptly produce 11–4. Proc. Natl. Acad. Sci. USA (1996) in press.
   Google Scholar
• MARSH DG, NEELY JD, BREAZEALE DR, GHOSH B, FRIED-HOFF LR, EHRLICH-KAUTZY E, SCHOU C, KRISH-NASWAMY G, BEATY TH: Linkage analysis of 11–4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science (1994) 264:1152–1156.
   Google Scholar
• PARRONCHI P, DE CARLI M, MANETTI R, SIMONELLI C, SAMPOGNARO S, PICCINNI M-P, MACCHIA D, MAGGI E, DEL PRETE G-F, ROMAGNANI S: 11-4 and IFN(s) (alpha and gamma) exert opposite regulatory effects on the development of eytolytic potential by Thl or Th2 hu-man T-cell clones. J. Immunol. (1992) 149:2977–2982.
   PubMed Web of Science ®Google Scholar
• CHEHIMI J, TRINCHIERI G: Interleukin-12: a bridge be-tween innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. (1994) 14:149–161.
   PubMed Web of Science ®Google Scholar
• MANETTI R, PARRONCHI P, GIUDIZI M-G, PICCINNI M-P, MAGGI E,TRICHIERI G, ROMAGNANI S: Natural killer cell stimulatory factor (interleukin 12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of 11-4-producing Th cells. J. Exp. Med. (1993) 177:1199–1204.
   PubMed Web of Science ®Google Scholar
• HOYNE OF, KRISTENSEN NM, YSSEL H, LAMB JR: Peptide modulation of allergen-specific immune responses. Curr. Opin. Immunol. (1995) 7:757–761.
   PubMedGoogle Scholar
• NORMAN PS, OHMAN JL, LONG AA: Clinical experience with T-cell reactive peptides from cat allergen Fel d 1. J. Allergy Clin. Immunol. (1994) 93:231 (abstract).
   Google Scholar
• GILBERT KM, HOANG KD, WIEGLE WO: Thl and Th2 clones differ in their response to tolerogenic signal. J. Immunol. (1990) 144:2063–2071.
   PubMed Web of Science ®Google Scholar
• WILLIAMS ME, SHEA CM, LICHTMAN AH, ABBAS AK: Anti-gen receptor-mediated anergy in resting T lymphocytes and T-cell clones: correlation with lymphokine secre-tion patterns. J. Immunol. (1992) 149:1921–1926.
   PubMedGoogle Scholar
• ROMBALL CG, WEIGLE WO: In vivo induction of toler-ance in murine CD4+ cell subsets. J. Exp. Med. (1993) 178:1637–1644.
   PubMed Web of Science ®Google Scholar
• GARSIDE P, STEEL M, WORTHEY EA, SATOSKAR A, ALEX-ANDER J, BLUETHMANN H, HEW FY, MOWAT AM: T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunot (1995) 154:5649–5655.
   Google Scholar
• PEREZ VL, LEDERER JA, L1CHTMAN AH, ABBAS AK: Stabil-ity of Thl and Th2 populations. Intern. Irnmunot (1995) 7:869–874
   PubMedGoogle Scholar
• NABORS GS, AFONSO LCC, FARELL JP, SCOTT P: Switchfrom a type 2 to a type 1 T helper cell response and cure of established Leisbmania major infection in mice is induced by combined therapy with interleukin 12 and pentosam. Proc. Natl. Acad. Sao USA (1995) 92:3142–3146.
   PubMedGoogle Scholar
• LACK G, RENZ H, SALOGA J, BRADLEY ILL, LOADER J,LEUNG DYM, LARSEN G, GELFAND EW: Nebulised but not parenteral IFN-y decreases IgE production and normal-ises airways function in a murine model of allergen sensitisation. J. Immunol. (1994) 152:2546–2554.
   PubMed Web of Science ®Google Scholar
• RENZ H, ENSSLE K, LAUFFER L, KURRLE R, GELFAND EW:Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor (sIL-4R). Int. Arcbs. Alletgy Im-munot (1995) 106:46–54.
   PubMedGoogle Scholar
• EGAN RW, ATHWAHL D, CHOU C-C, EMTAGE S, JEHN C-H,KUNG TT, MAUSER PJ, MURGOLO NJ, BODMER MW: Inhibition of pulmonary eosinophiLla and hyper-reac-tivity by antibodies to interleukin-5. Int. Arcbs. Allergy Immunot (1995) 107:321–322.
   PubMed Web of Science ®Google Scholar
• KUNG TT, STELTS DM, ZURCHER JA, ADAMS GK, EGAN RW, KREUTNER W, WATNICK AS, JONES H, CHAPMAN RW: Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeu-tic effect of anti-IL-5 antibody. Am.J. Respir. Cell Mot Biol. (1995) 13:360–365.
   PubMed Web of Science ®Google Scholar
• MORI A, SUKO M, KAMINUMA P, NISHIZAKI Y, NAGAHOR1 T, MIKAMI T, OHMURA T, HOSINO A, HASAKURA Y, OKUDAIRA H: Enhanced production and gene expres-sion of IL-5 in bronchial asthma. Possible management of atopic diseases with IL-5 specific gene transcription Inhibitor. In: Molecular Biology of Allergens, and the Atopic Immune Response, Sehon A and Kraft D (Eds.) Plenum Press, New York, (1996) in press.
   Google Scholar
• JARDIEU P: Anti-IgE therapy. Curr. Opin. Immunol. (1995) 7:779–782.
   PubMedGoogle Scholar